Gilead Sciences Inc
(GILD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 22,449,000 | 22,127,000 | 26,107,000 | 30,390,000 | 32,639,000 |
| Cost of Goods | 4,675,000 | 4,853,000 | 4,371,000 | 4,261,000 | 4,006,000 |
| Gross Profit | 17,774,000 | 17,274,000 | 21,736,000 | 26,129,000 | 28,633,000 |
| Operating Expenses | 13,487,000 | 9,074,000 | 7,612,000 | 8,496,000 | 6,440,000 |
| Operating Income | 4,287,000 | 8,200,000 | 14,124,000 | 17,633,000 | 22,193,000 |
| Interest Expense | 995,000 | 1,077,000 | 1,118,000 | 964,000 | 688,000 |
| Other Income | 1,868,000 | 676,000 | 523,000 | 428,000 | 154,000 |
| Pre-tax Income | 5,160,000 | 7,799,000 | 13,529,000 | 17,097,000 | 21,659,000 |
| Income Tax | -204,000 | 2,339,000 | 8,885,000 | 3,609,000 | 3,553,000 |
| Net Income Continuous | 5,364,000 | 5,460,000 | 4,644,000 | 13,488,000 | 18,106,000 |
| Minority Interests | -22,000 | 5,000 | 16,000 | -13,000 | -2,000 |
| Net Income | $5,386,000 | $5,455,000 | $4,628,000 | $13,501,000 | $18,108,000 |
| EPS Basic Total Ops | 4.24 | 4.20 | 3.54 | 10.08 | 12.37 |
| EPS Basic Continuous Ops | 4.22 | 4.21 | 3.55 | 10.07 | 12.37 |
| EPS Diluted Total Ops | 4.22 | 4.17 | 3.51 | 9.94 | 11.91 |
| EPS Diluted Continuous Ops | 4.20 | 4.17 | 3.52 | 9.93 | 11.90 |
| EPS Diluted Before Non-Recurring Items | 6.14 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $5,691,000 | $9,629,000 | $15,410,000 | $18,791,000 | $23,291,000 |